About this Journal Submit a Manuscript Table of Contents
Arthritis
Volume 2012 (2012), Article ID 601763, 11 pages
http://dx.doi.org/10.1155/2012/601763
Review Article

The Pathogenesis of Nontraumatic Osteonecrosis

Department of Orthopaedic Surgery, University of Virginia School of Medicine, 400 Ray C. Hunt Drive, Box 800159, Charlottesville, VA 22908, USA

Received 24 June 2012; Accepted 28 October 2012

Academic Editor: Pierre Youinou

Copyright © 2012 Jesse Seamon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Arlet, “Nontraumatic avascular necrosis of the femoral head: past, present, and future,” Clinical Orthopaedics and Related Research, no. 277, pp. 12–21, 1992. View at Scopus
  2. B. Jacobs, “Epidemiology of traumatic and nontraumatic osteonecrosis,” Clinical Orthopaedics and Related Research, vol. 130, pp. 51–67, 1978. View at Scopus
  3. M. A. Mont and D. S. Hungerford, “Non-traumatic avascular necrosis of the femoral head,” Journal of Bone and Joint Surgery, vol. 77, no. 3, pp. 459–474, 1995. View at Scopus
  4. M. A. Mont, L. C. Jones, and D. S. Hungerford, “Current concepts review—nontraumatic osteonecrosis of the femoral head: ten years later,” Journal of Bone and Joint Surgery, vol. 88, no. 5, pp. 1117–1132, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Mont, G. A. Marulanda, L. C. Jones et al., “Systematic analysis of classification systems for osteonecrosis of the femoral head,” Journal of Bone and Joint Surgery, vol. 88, no. 3, pp. 16–26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Etienne, M. A. Mont, and P. S. Ragland, “The diagnosis and treatment of nontraumatic osteonecrosis of the femoral head,” Instructional Course Lectures, vol. 53, pp. 67–85, 2004. View at Scopus
  7. D. S. Hungerford and D. W. Lennox, “The importance of increased intraosseous pressure in the development of osteonecrosis of the femoral head: implications for treatment,” Orthopedic Clinics of North America, vol. 16, no. 4, pp. 635–654, 1985. View at Scopus
  8. M. Sakaguchi, T. Tanaka, W. Fukushima, T. Kubo, and Y. Hirota, “Impact of oral corticosteroid use for idiopathic osteonecrosis of the femoral head: a nationwide multicenter case-control study in Japan,” Journal of Orthopaedic Science, vol. 15, no. 2, pp. 185–191, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Zaidi, L. Sun, L. J. Robinson et al., “ACTH protects against glucocorticoid-induced osteonecrosis of bone,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 19, pp. 8782–8787, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Wang, Y. Li, K. Mao, J. Li, Q. Cui, and G. J. Wang, “Alcohol-induced adipogenesis in bone and marrow: a possible mechanism for osteonecrosis,” Clinical Orthopaedics and Related Research, no. 410, pp. 213–224, 2003. View at Scopus
  11. M. Abu-Shakra, D. Buskila, and Y. Shoenfeld, “Osteonecrosis in patients with SLE,” Clinical Reviews in Allergy and Immunology, vol. 25, no. 1, pp. 13–23, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. A. L. Akinyoola, I. A. Adediran, C. M. Asaleye, and A. R. Bolarinwa, “Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease,” International Orthopaedics, vol. 33, no. 4, pp. 923–926, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Buck and S. C. Davies, “Surgery in sickle cell disease,” Hematology/Oncology Clinics of North America, vol. 19, no. 5, pp. 897–902, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. M. Mukisi, K. Bashoun, and F. Burny, “Sickle-cell hip necrosis and intraosseous pressure,” Orthopaedics and Traumatology: Surgery and Research, vol. 95, no. 2, pp. 134–138, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. E. J. Wall, “Legg-Calve-Perthes' disease,” Current Opinion in Pediatrics, vol. 11, no. 1, pp. 76–79, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. J. C. Rueda, M. A. Q. Duque, R. D. Mantilla, and A. Iglesias-Gamarra, “Osteonecrosis and antiphospholipid syndrome,” Journal of Clinical Rheumatology, vol. 15, no. 3, pp. 130–132, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Shim, M. J. MacKenzie, and E. Winquist, “Chemotherapy-associated osteonecrosis in cancer patients with solid tumours: a systematic review,” Drug Safety, vol. 31, no. 5, pp. 359–371, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Bubbar, F. Las Heras, D. Amato, K. P. H. Pritzker, and A. E. Gross, “Total hip replacement in Gaucher's disease: effects of enzyme replacement therapy,” Journal of Bone and Joint Surgery, vol. 91, no. 12, pp. 1623–1627, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Lebel, M. Phillips, D. Elstein, A. Zimran, and M. Itzchaki, “Poor results of drilling in early stages of juxta-articular osteonecrosis in 12 joints affected by Gaucher disease,” Acta Orthopaedica, vol. 80, no. 2, pp. 201–204, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. A. Matos, R. W. de Alencar, and S. S. da Rocha Matos, “Avascular necrosis of the femoral head in HIV infected patients,” Brazilian Journal of Infectious Diseases, vol. 11, no. 1, pp. 31–34, 2007. View at Scopus
  21. J. R. Lieberman, D. J. Berry, M. A. Mont et al., “Osteonecrosis of the hip: management in the 21st century,” Instructional Course Lectures, vol. 52, pp. 337–355, 2003. View at Scopus
  22. D. P. Baksi, A. K. Pal, and D. D. Baksi, “Long-term results of decompression and muscle-pedicle bone grafting for osteonecrosis of the femoral head,” International Orthopaedics, vol. 33, no. 1, pp. 41–47, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Assouline-Dayan, C. Chang, A. Greenspan, Y. Shoenfeld, and M. E. Gershwin, “Pathogenesis and natural history of osteonecrosis,” Seminars in Arthritis and Rheumatism, vol. 32, no. 2, pp. 94–124, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. R. K. Aaron, “Osteonecrosis: etiology, pathophysiology and diagnosis,” in The Adult Hip, J. J. Callaghan, A. G. Rosenberg, and H. Rubash, Eds., Lippencott-Raven, Philadelphia, Pa, USA, 1998.
  25. J. E. Kenzora and M. J. Glimcher, “Accumulative cell stress: the multifactorial etiology of idiopathic osteonecrosis,” Orthopedic Clinics of North America, vol. 16, no. 4, pp. 669–679, 1985. View at Scopus
  26. L. C. Jones and D. S. Hungerford, “Osteonecrosis: etiology, diagnosis, and treatment,” Current Opinion in Rheumatology, vol. 16, no. 4, pp. 443–449, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Adekile, M. Z. Haider, R. Marouf, and A. D. Adekile, “HLA-DRB1 alleles in Hb SS patients with avascular necrosis of the femoral head,” American Journal of Hematology, vol. 79, no. 1, pp. 8–10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. J. D. Chang, M. Hur, S. S. Lee, J. H. Yoo, and K. M. Lee, “Genetic background of nontraumatic osteonecrosis of the femoral head in the Korean population,” Clinical Orthopaedics and Related Research, vol. 466, no. 5, pp. 1041–1046, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. C. Chao, S. J. Wang, H. C. Chu, W. K. Chang, and T. Y. Hsieh, “Investigation of alcohol metabolizing enzyme genes in Chinese alcoholics with avascular necrosis of hip joint, pancreatitis and cirrhosis of the liver,” Alcohol and Alcoholism, vol. 38, no. 5, pp. 431–436, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. W. M. Chen, Y. F. Liu, M. W. Lin et al., “Autosomal dominant avascular necrosis of femoral head in two Taiwanese pedigrees and linkage to chromosome 12q13,” American Journal of Human Genetics, vol. 75, no. 2, pp. 310–317, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. X. L. Dai, J. M. Hong, B. Oh et al., “Association analysis of Tissue factor pathway inhibitor polymorphisms and haplotypes with Osteonecrosis of the femoral head in the Korean population,” Molecules and Cells, vol. 26, no. 5, pp. 490–495, 2008. View at Scopus
  32. C. J. Glueck, R. Freiberg, T. Tracy, D. Stroop, and P. Wang, “Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis,” Clinical Orthopaedics and Related Research, no. 334, pp. 43–56, 1997. View at Scopus
  33. C. J. Glueck, R. A. Freiberg, S. Boppana, and P. Wang, “Thrombophilia, hypofibrinolysis, the eNOS T-786C polymorphism, and multifocal osteonecrosis,” Journal of Bone and Joint Surgery, vol. 90, no. 10, pp. 2220–2229, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. C. J. Glueck, R. A. Freiberg, R. N. Fontaine, T. Tracy, and P. Wang, “Hypofibrinolysis, thrombophilia, osteonecrosis,” Clinical Orthopaedics and Related Research, no. 386, pp. 19–33, 2001. View at Scopus
  35. C. J. Glueck, R. A. Freiberg, J. Oghene, R. N. Fontaine, and P. Wang, “Association between the T-786C eNOS polymorphism and idiopathic osteonecrosis of the head of the femur,” Journal of Bone and Joint Surgery, vol. 89, no. 11, pp. 2460–2468, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Hadjigeorgiou, E. Dardiotis, M. Dardioti, A. Karantanas, A. Dimitroulias, and K. Malizos, “Genetic association studies in osteonecrosis of the femoral head: mini review of the literature,” Skeletal Radiology, vol. 37, no. 1, pp. 1–7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. W. He and K. Li, “Incidence of genetic polymorphisms involved in lipid metabolism among Chinese patients with osteonecrosis of the femoral head,” Acta orthopaedica, vol. 80, no. 3, pp. 325–329, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. J. M. Hong, T. H. Kim, H. J. Kim, E. K. Park, E. K. Yang, and S. Y. Kim, “Genetic association of angiogenesis- and hypoxia-related gene polymorphisms with osteonecrosis of the femoral head,” Experimental and Molecular Medicine, vol. 42, no. 5, pp. 376–385, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. D. S. Hungerford and L. C. Jones, “Asymptomatic osteonecrosis: should it be treated?” Clinical Orthopaedics and Related Research, no. 429, pp. 124–130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. L. C. Jones, M. A. Mont, T. B. Le et al., “Procoagulants and osteonecrosis,” Journal of Rheumatology, vol. 30, no. 4, pp. 783–791, 2003. View at Scopus
  41. T. H. Kim, J. I. Baek, J. M. Hong et al., “Significant association of SREBP-2 genetic polymorphisms with avascular necrosis in the Korean population,” BMC Medical Genetics, vol. 9, article 94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. T. H. Kim, J. M. Hong, H. J. Kim, E. K. Park, and S. Y. Kim, “Lack of association of MTHFR gene polymorphisms with the risk of osteonecrosis of the femoral head in a Korean population,” Molecules and Cells, vol. 29, no. 4, pp. 343–348, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. T. H. Kim, J. M. Hong, J. Y. Lee et al., “Promoter polymorphisms of the vascular endothelial growth factor gene is associated with an osteonecrosis of the femoral head in the Korean population,” Osteoarthritis and Cartilage, vol. 16, no. 3, pp. 287–291, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. T. H. Kim, J. M. Hong, B. Oh et al., “Association of polymorphisms in the Interleukin 23 receptor gene with osteonecrosis of femoral head in Korean population,” Experimental and Molecular Medicine, vol. 40, no. 4, pp. 418–426, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. T. H. Kim, J. M. Hong, B. Oh et al., “Genetic association study of polymorphisms in the catalase gene with the risk of osteonecrosis of the femoral head in the Korean population,” Osteoarthritis and Cartilage, vol. 16, no. 9, pp. 1060–1066, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. T. H. Kim, J. M. Hong, E. S. Shin et al., “Polymorphisms in the Annexin gene family and the risk of osteonecrosis of the femoral head in the Korean population,” Bone, vol. 45, no. 1, pp. 125–131, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. K. H. Koo, J. S. Lee, Y. J. Lee, K. J. Kim, J. J. Yoo, and H. J. Kim, “Endothelial nitric oxide synthase gene polymorphisms in patients with nontraumatic femoral head osteonecrosis,” Journal of Orthopaedic Research, vol. 24, no. 8, pp. 1722–1728, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Kuribayashi, M. Fujioka, K. A. Takahashi et al., “Combination analysis of three polymorphisms for predicting the risk for steroid-induced osteonecrosis of the femoral head,” Journal of Orthopaedic Science, vol. 13, no. 4, pp. 297–303, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Pierre-Jacques, C. J. Glueck, M. A. Mont, and D. S. Hungerford, “Familial heterozygous protein-s deficiency in a patient who had multifocal osteonecrosis: a case report,” Journal of Bone and Joint Surgery, vol. 79, no. 7, pp. 1079–1084, 1997. View at Scopus
  50. C. G. Zalavras, G. Vartholomatos, E. Dokou, and K. N. Malizos, “Genetic background of osteonecrosis: associated with thrombophilic mutations?” Clinical Orthopaedics and Related Research, no. 422, pp. 251–255, 2004. View at Scopus
  51. C. J. Glueck, R. A. Freiberg, and P. Wang, “Heritable thrombophilia-hypofibrinolysis and osteonecrosis of the femoral head,” Clinical Orthopaedics and Related Research, vol. 466, no. 5, pp. 1034–1040, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. J. P. Jones Jr., “Fat embolism, intravascular coagulation, and osteonecrosis,” Clinical Orthopaedics and Related Research, no. 292, pp. 294–308, 1993. View at Scopus
  53. Q. Cui, G. J. Wang, and G. Balian, “Steroid-induced adipogenesis in a pluripotential cell line from bone marrow,” Journal of Bone and Joint Surgery, vol. 79, no. 7, pp. 1054–1063, 1997. View at Scopus
  54. Q. Cui, G. J. Wang, C. C. Su, and G. Balian, “Lovastatin prevents steroid induced adipogenesis and osteonecrosis,” Clinical Orthopaedics and Related Research, no. 344, pp. 8–19, 1997. View at Scopus
  55. X. Li, Q. Cui, C. Kao, G. J. Wang, and G. Balian, “Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARγ2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures,” Bone, vol. 33, no. 4, pp. 652–659, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. X. Li, L. Jin, Q. Cui, G. J. Wang, and G. Balian, “Steroid effects on osteogenesis through mesenchymal cell gene expression,” Osteoporosis International, vol. 16, no. 1, pp. 101–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. W. Drescher, M. H. Bünger, K. Weigert, C. Bünger, and E. S. Hansen, “Methylprednisolone enhances contraction of porcine femoral head epiphyseal arteries,” Clinical Orthopaedics and Related Research, no. 423, pp. 112–117, 2004. View at Scopus
  58. Y. Feng, S. H. Yang, B. J. Xiao et al., “Decreased in the number and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head,” Bone, vol. 46, no. 1, pp. 32–40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Kabata, T. Matsumoto, S. Yagishita, T. Wakayama, S. Iseki, and K. Tomita, “Vascular endothelial growth factor in rabbits during development of corticosteroid-induced osteonecrosis: a controlled experiment,” Journal of Rheumatology, vol. 35, no. 12, pp. 2383–2390, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. Kaneshiro, Y. Oda, K. Iwakiri et al., “Low hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosis,” Clinical Pharmacology and Therapeutics, vol. 80, no. 4, pp. 396–402, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. M. A. Kerachian, C. Séguin, and E. J. Harvey, “Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action,” Journal of Steroid Biochemistry and Molecular Biology, vol. 114, no. 3-5, pp. 121–128, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Kitajima, M. Shigematsu, K. Ogawa, H. Sugihara, and T. Hotokebuchi, “Effects of glucocorticoid on adipocyte size in human bone marrow,” Medical Molecular Morphology, vol. 40, no. 3, pp. 150–156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. T. Masada, K. Iwakiri, Y. Oda et al., “Increased hepatic cytochrome P4503A activity decreases the risk of developing steroid-induced osteonecrosis in a rabbit model,” Journal of Orthopaedic Research, vol. 26, no. 1, pp. 91–95, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Okazaki, Y. Nishitani, S. Nagoya, M. Kaya, T. Yamashita, and H. Matsumoto, “Femoral head osteonecrosis can be caused by disruption of the systemic immune response via the toll-like receptor 4 signalling pathway,” Rheumatology, vol. 48, no. 3, pp. 227–232, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. K. T. Suh, S. W. Kim, H. L. Roh, M. S. Youn, and J. S. Jung, “Decreased osteogenic differentiation of mesenchymal stem cells in alcohol-induced osteonecrosis,” Clinical Orthopaedics and Related Research, no. 431, pp. 220–225, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Takano-Murakami, K. Tokunaga, N. Kondo et al., “Glucocorticoid inhibits bone regeneration after osteonecrosis of the femoral head in aged female rats,” Tohoku Journal of Experimental Medicine, vol. 217, no. 1, pp. 51–58, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. D. Varoga, W. Drescher, M. Pufe, G. Groth, and T. Pufe, “Differential expression of vascular endothelial growth factor in glucocorticoid-related osteonecrosis of the femoral head,” Clinical Orthopaedics and Related Research, vol. 467, no. 12, pp. 3273–3282, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. B. L. Wang, W. Sun, Z. C. Shi et al., “Decreased proliferation of mesenchymal stem cells in corticosteroid-induced osteonecrosis of femoral head,” Orthopedics, vol. 31, no. 5, p. 444, 2008. View at Scopus
  69. Y. Wang, L. Yin, Y. Li, P. Liu, and Q. Cui, “Preventive effects of puerarin on alcohol-induced osteonecrosis,” Clinical Orthopaedics and Related Research, vol. 466, no. 5, pp. 1059–1067, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. R. S. Weinstein, R. W. Nicholas, and S. C. Manolagas, “Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 8, pp. 2907–2912, 2000. View at Publisher · View at Google Scholar · View at Scopus
  71. L. Yin, Y. B. Li, and Y. S. Wang, “Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: mechanism of steroid-induced osteonecrosis,” Chinese Medical Journal, vol. 119, no. 7, pp. 581–588, 2006. View at Scopus
  72. C. J. Glueck, R. A. Freiberg, A. Crawford et al., “Secondhand smoke, hypofibrinolysis, and Legg-Perthes disease,” Clinical Orthopaedics and Related Research, no. 352, pp. 159–167, 1998. View at Scopus
  73. T. Asano, K. A. Takahashi, M. Fujioka et al., “ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantation,” Pharmacogenetics, vol. 13, no. 11, pp. 675–682, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. J. W. Pritchett, “Statin therapy decreases the risk of osteonecrosis in patients receiving steroids,” Clinical Orthopaedics and Related Research, no. 386, pp. 173–178, 2001. View at Scopus
  75. C. J. Glueck, R. A. Freiberg, L. Sieve, and P. Wang, “Enoxaparin prevents progression of Stages I and II osteonecrosis of the hip,” Clinical Orthopaedics and Related Research, no. 435, pp. 164–170, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. J. P. Jones Jr., “Fat embolism and osteonecrosis,” Orthopedic Clinics of North America, vol. 16, no. 4, pp. 595–633, 1985. View at Scopus
  77. J. Paul-Jones Jr., “Intravascular coagulation and osteonecrosis,” Clinical Orthopaedics and Related Research, no. 277, pp. 41–53, 1992. View at Scopus
  78. J. P. Jones Jr., “Alcoholism, hypercortisonism, fat embolism and osseous avascular necrosis. 1971,” Clinical Orthopaedics and Related Research, no. 393, pp. 4–12, 2001. View at Scopus
  79. G. J. Wang, Q. Cui, and G. Balian, “The pathogenesis and prevention of steroid induced osteonecrosis,” Clinical Orthopaedics and Related Research, no. 370, pp. 295–310, 2000. View at Scopus
  80. G. J. Wang, D. E. Sweet, and S. I. Reger, “Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits,” Journal of Bone and Joint Surgery, vol. 59, no. 6, pp. 729–735, 1977. View at Scopus
  81. S. Day, R. F. Ostrum, E. Y. S. Chao, C. T. Rubin, H. T. Aro, and T. A. Einhorn, “Bone injury, regeneration and repair,” in Orthopaedic Basic Science: Biology and Biomechanics of the Musculoskeletal System, J. Buckwalter, T. A. Einhorn, and S. R. Simon, Eds., pp. 372–375, American Academy of Orthopaedic Surgeons, Rosemont, Ill, USA.
  82. M. J. Glimcher and J. E. Kenzora, “The biology of osteonecrosis of the human femoral head and its clinical implications: II. The pathological changes in the femoral head as an organ and in the hip joint,” Clinical Orthopaedics and Related Research, vol. 139, pp. 283–312, 1979. View at Scopus
  83. M. J. Glimcher and J. E. Kenzora, “The biology of osteonecrosis of the human femoral head and its clinical implication: I. Tissue biology,” Clinical Orthopaedics and Related Research, vol. 138, pp. 284–309, 1979. View at Scopus
  84. M. J. Glimcher and J. E. Kenzora, “The biology of osteonecrosis of the human femoral head and its clinical implications. III. Discussion of the etiology and genesis of the pathological sequelae; comments on treatment,” Clinical Orthopaedics and Related Research, vol. 140, pp. 273–312, 1979. View at Scopus
  85. D. B. Phemister, “Repair of bone in the presence of aseptic necrosis resulting from fractures, transplantations, and vascular obstruction,” Journal of Bone and Joint Surgery, vol. 87, no. 3, p. 672, 2005. View at Scopus
  86. D. B. Phemister, “Treatment of the necrotic head of the femur in adults,” The Journal of Bone & Joint Surgery, vol. 1, pp. 55–66, 1949.
  87. F. A. Chandler, “Coronary disease of the hip. 1949,” Clinical Orthopaedics and Related Research, no. 386, pp. 7–10, 2001. View at Scopus
  88. T. Atsumi, Y. Kuroki, and K. Yamano, “A microangiographic study of idiopathic osteonecrosis of the femoral head,” Clinical Orthopaedics and Related Research, no. 246, pp. 186–194, 1989. View at Scopus
  89. R. L. Cruess, “Osteonecrosis of bone: current concepts as to etiology and pathogenesis,” Clinical Orthopaedics and Related Research, vol. 208, pp. 30–39, 1986. View at Scopus
  90. D. S. Hungerford and T. M. Zizic, “Pathogenesis of ischemic necrosis of the femoral head,” The Hip, pp. 249–262, 1983. View at Scopus
  91. J. P. Jones Jr. and A. R. Behnke Jr., “Prevention of dysbaric osteonecrosis in compressed air workers,” Clinical Orthopaedics and Related Research, vol. 130, pp. 118–128, 1978. View at Scopus
  92. T. Asano, K. A. Takahashi, M. Fujioka et al., “Genetic analysis of steroid-induced osteonecrosis of the femoral head,” Journal of Orthopaedic Science, vol. 8, no. 3, pp. 329–333, 2003. View at Publisher · View at Google Scholar · View at Scopus
  93. C. J. Glueck, R. N. Fontaine, R. Gruppo et al., “The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis,” Clinical Orthopaedics and Related Research, no. 366, pp. 133–146, 1999. View at Scopus
  94. S. Inoue, M. Horii, T. Asano et al., “Risk factors for nontraumatic osteonecrosis of the femoral head after renal transplantation,” Journal of Orthopaedic Science, vol. 8, no. 6, pp. 751–756, 2003. View at Publisher · View at Google Scholar · View at Scopus
  95. F. R. Al-Mousawi and A. A. Malki, “Managing femoral head osteonecrosis in patients with sickle cell disease,” Surgeon, vol. 5, no. 5, pp. 282–289, 2007. View at Scopus
  96. A. De Gheldere, R. Ndjoko, P. L. Docquier, M. Mousny, and J. J. Rombouts, “Orthopaedic complications associated with sickle-cell disease,” Acta Orthopaedica Belgica, vol. 72, no. 6, pp. 741–747, 2006. View at Scopus
  97. S. P. Eholié, M. Ouiminga, E. Ehui et al., “Avascular osteonecrosis of the femoral head in three West African HIV-infected adults with heterozygous sickle cell disease,” Antiviral Therapy, vol. 14, no. 7, pp. 1011–1014, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Mukisi-Mukaza, O. Manicom, C. Alexis, K. Bashoun, M. Donkerwolcke, and F. Burny, “Treatment of Sickle cell disease's hip necrosis by core decompression: a prospective case-control study,” Orthopaedics and Traumatology: Surgery and Research, vol. 95, no. 7, pp. 498–504, 2009. View at Publisher · View at Google Scholar · View at Scopus
  99. A. Björkman, P. J. Svensson, A. Hillarp, I. M. Burtscher, A. Rünow, and G. Benoni, “Factor V Leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults,” Clinical Orthopaedics and Related Research, no. 425, pp. 168–172, 2004. View at Scopus
  100. J. W. Kemper, A. H. Baggenstoss, and C. H. Slocumb, “The relationship of therapy with cortisone to the incidence of vascular lesions in rheumatoid arthritis,” Annals of Internal Medicine, vol. 5, pp. 831–851, 1957.
  101. K. H. Koo, R. Kim, Y. S. Kim et al., “Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment,” Clinical Rheumatology, vol. 21, no. 4, pp. 299–303, 2002. View at Publisher · View at Google Scholar · View at Scopus
  102. K. Nagasawa, Y. Tada, S. Koarada et al., “Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI,” Lupus, vol. 14, no. 5, pp. 385–390, 2005. View at Publisher · View at Google Scholar · View at Scopus
  103. D. E. Fisher, “The role of fat embolism in the etiology of corticosteroid induced avascular necrosis: clinical and experimental results,” Clinical Orthopaedics and Related Research, vol. 130, pp. 68–80, 1978. View at Scopus
  104. E. W. Gold, O. D. Fox, S. Weissfeld, and P. H. Curtiss, “Corticosteroid-induced avascular necrosis: an experimental study in rabbits,” Clinical Orthopaedics and Related Research, vol. 135, pp. 272–280, 1978. View at Scopus
  105. K. Miyanishi, T. Yamamoto, T. Irisa et al., “Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis,” Bone, vol. 30, no. 1, pp. 185–190, 2002. View at Publisher · View at Google Scholar · View at Scopus
  106. J. J. P. Warner, J. H. Philips, G. L. Brodsky, and T. S. Thornhill, “Studies of nontraumatic osteonecrosis. Manometric and histologic studies of the femoral head after chronic steroid treatment: an experimental study in rabbits,” Clinical Orthopaedics and Related Research, no. 225, pp. 128–140, 1987. View at Scopus
  107. R. S. Weinstein, R. L. Jilka, A. Michael Parfitt, and S. C. Manolagas, “Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts end osteocytes by glucocorticoids potential mechanisms of their deleterious effects on bone,” Journal of Clinical Investigation, vol. 102, no. 2, pp. 274–282, 1998. View at Scopus
  108. Q. Cui, G. J. Wang, and G. Balian, “Pluripotential marrow cells produce adipocytes when transplanted into steroid-treated mice,” Connective Tissue Research, vol. 41, no. 1, pp. 45–56, 2000. View at Scopus
  109. W. Drescher, T. Schneider, C. Becker et al., “Effect of methylprednisolone on reperfusion after femoral head ischemia,” Clinical Orthopaedics and Related Research, no. 402, pp. 270–277, 2002. View at Scopus
  110. Q. Zhong, S. Sridhar, L. Ruan et al., “Multiple melanocortin receptors are expressed in bone cells,” Bone, vol. 36, no. 5, pp. 820–831, 2005. View at Publisher · View at Google Scholar · View at Scopus
  111. K. Matsuo, T. Hirohata, Y. Sugioka, M. Ikeda, and A. Fukuda, “Influence of alcohol intake, cigarette smoking, and occupational status on idiopathic osteonecrosis of the femoral head,” Clinical Orthopaedics and Related Research, no. 234, pp. 115–123, 1988. View at Scopus
  112. D. T. Felson and J. J. Anderson, “Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone,” The Lancet, vol. 1, no. 8538, pp. 902–905, 1987. View at Scopus
  113. D. Weldon, “The effects of corticosteroids on bone: osteonecrosis (avascular necrosis of the bone),” Annals of Allergy, Asthma and Immunology, vol. 103, no. 2, pp. 91–98, 2009. View at Publisher · View at Google Scholar · View at Scopus
  114. S. Iida, Y. Harada, K. Shimizu et al., “Correlation between bone marrow edema and collapse of the femoral head in steroid-induced osteonecrosis,” American Journal of Roentgenology, vol. 174, no. 3, pp. 735–743, 2000. View at Scopus